Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
The impact of sequential analysis on drug decision-making in Canada
Catherine Beauchemin
,
Jean Lachaine
,
Jean-Eric Tarride
,
Ana Rusu
, and
Stephane Barakat
Journal of Comparative Effectiveness Research
27 Oct 2026
Cost-effectiveness analysis of nanosecond pulsed field ablation against hemithyroidectomy and total thyroidectomy for benign thyroid nodules
Melissa Gomez Montero
,
Ralph P. Tufano
,
Victoria Zaitceva
,
Michael Branagan-Harris
,
Mehdi Javanbakht
, and
Amir Ansaripour
Journal of Comparative Effectiveness Research
26 Oct 2026
A dual mandate for branded drug prices
The Evidence Base
29 Oct 2026
Understanding the use of AI in the RWE research lifecycle: Why a living scoping review is needed
The Evidence Base
29 Oct 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
29 Oct 2026
Understanding the use of AI in the RWE research lifecycle: Why a living scoping review is needed
29 Oct 2026
Nordic VALO project demonstrates cross-border health data analysis
27 Oct 2026
FDA Grand Rounds RWE series: How real-world evidence informs regulatory decisions in digital health
26 Oct 2026
From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions
26 Oct 2026
WEBINAR: After the first JCA reports: How should comparative effectiveness be assessed? – January 27, 2027
21 Oct 2026
DIA’s 2026 Real-World Evidence Conference daily round-ups: Day 2
29 Oct 2026
A dual mandate for branded drug prices
26 Oct 2026
From defining value to reshaping evidence: What to expect from the ISPOR Europe 2026 plenary sessions
26 Oct 2026
WEBINAR: After the first JCA reports: How should comparative effectiveness be assessed? – January 27, 2027
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
29 Oct 2026
A dual mandate for branded drug prices
29 Oct 2026
Understanding the use of AI in the RWE research lifecycle: Why a living scoping review is needed
29 Oct 2026
Nordic VALO project demonstrates cross-border health data analysis
28 Oct 2026
CMS announces plans to broaden Cell and Gene Therapy Access Model beyond sickle cell disease
.png)
.png)
